Europe Postpartum Hemorrhage Market Forecast 2017-2025
The Europe Postpartum Hemorrhage market is anticipated to expand from $181 million in the year 2016 to $314 million in the year 2025 growing at a CAGR of 6.27% during the forecasted period 2017-2025. The base year is deliberated to be 2016 and the forecast period is from 2017 to 2025. Increasing awareness among people in developing countries for postpartum treatment and rising rate of postpartum hemorrhage are some of the dominant drivers in the postpartum hemorrhage market. Also, the rapid growth of risk factors in postpartum hemorrhage and educational initiatives by the government and training in regard to women’s health also acts as leading drivers in the postpartum hemorrhage market.
The postpartum hemorrhage market is segmented by type on the basis of Uterine Balloon Tamponade market, by Uniject prefilled Injection system and by Nonpneumatic anti-shock garment type market. The Uterine Balloon Tamponade market is further segmented on the basis of Foley Catheters market, Condom Catheters market and others.
Major players in the postpartum hemorrhage market are 3RD Stone design, Inc, Bactiguard AB, C.R.Bard,INC, Cook Medical, Inc, Avol Inc, Teleflex Incorporated, Utah medical products, Inc, Becton Dickinson and company, GE Healthcare, Program for Appropriate Technology in Health (PATH), Zoex Niasg, Inpress technologies.